PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
28-Oct-2024 Duhn Therapeutics, launched by Landmark BioVentures, signs global license agreement with OM Pharma to further advance clinical-stage, lipid-based cancer immunotherapy Duhn Therapeutics
28-Oct-2024 CluePoints Appoints Richard Young as Chief Strategy Officer CluePoints
28-Oct-2024 Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer Coronado Research
28-Oct-2024 2nd Global Summit on Vaccines and Immunology(GSVI2025) Apex Global Meetings
25-Oct-2024 HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 HighTide Therapeutics
25-Oct-2024 CD Bioparticles Announces New Line of Liposomes for Food Applications CD Bioparticles
25-Oct-2024 CD Bioparticles Introduces New Line of NIST Traceable Polystyrene Particle Size Standards CD Bioparticles
25-Oct-2024 CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage CD BioSciences
25-Oct-2024 STEMart Introduces Advanced Accelerated Aging Testing Services for Medical Devices STEMart
25-Oct-2024 Creative Diagnostics Releases Yeast DNA Residue Assay Kits (qPCR) for Biological Research Creative Diagnostics
25-Oct-2024 Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications Creative Diagnostics
25-Oct-2024 Creative Diagnostics Launches Advanced Influenza A Virus Mouse Models for Accelerated Research Creative Diagnostics
25-Oct-2024 H5N1 Antibodies and Antigens for Research Applications Creative Diagnostics
25-Oct-2024 Success Stories: Graduates of Clinical Research Courses with 100% Placement Fusion Technology Solutions
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech Innovate UK
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech SynaptixBio
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics N.V.
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics